Difficulty: Medium
Average Score: 68%
Practice
A woman of childbearing age is diagnosed with breast cancer. She is currently taking hormonal contraceptives. What information should the woman be given regarding the hormonal contraceptives?
Correct answer
D
Rationale
In women with breast cancer, hormonal contraceptives, which contain estrogen and progestin, can exacerbate the disease. Many breast cancers are hormone-sensitive, meaning estrogen can fuel tumor growth by binding to receptors on cancer cells, accelerating proliferation. Continuing these medications during a breast cancer diagnosis risks worsening the condition, necessitating their discontinuation. They don't directly influence uterine bleeding in this context, nor are they neutral to the disease's progression; their hormonal effects are significant. Informing the woman of this risk ensures she understands the potential for tumor stimulation, prompting a switch to non-hormonal contraception methods. This guidance aligns with clinical evidence linking estrogen exposure to adverse outcomes in hormone-dependent cancers, prioritizing disease management and patient safety.